BIONET Corp. (TPEX:1784)
Taiwan · Delayed Price · Currency is TWD 103.50
+3.70 (3.71%)
Oct 31, 2025, 2:32 PM CST
BIONET Market Cap
BIONET has a market cap or net worth of 5.5 billion as of October 31, 2025. Its market cap has increased by 9.88% in one year.
Market Cap
5.50B
Enterprise Value
5.05B
Revenue
1.23B
Ranking
n/a
PE Ratio
73.90
Stock Price
103.50
Market Cap Chart
Since November 3, 2008, BIONET's market cap has increased from 1.14B to 5.50B, an increase of 380.78%. That is a compound annual growth rate of 9.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 5.50B | 36.35% |
| Dec 31, 2024 | 4.03B | 47.30% |
| Dec 29, 2023 | 2.74B | 32.70% |
| Dec 30, 2022 | 2.06B | 9.73% |
| Dec 30, 2021 | 1.88B | -2.06% |
| Dec 31, 2020 | 1.92B | -0.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 233.43B |
| PharmaEssentia | 184.18B |
| Lotus Pharmaceutical | 77.71B |
| Bora Pharmaceuticals Co., LTD. | 77.08B |
| Lumosa Therapeutics | 35.38B |
| Oneness Biotech | 30.99B |
| Pegavision | 26.56B |
| Polaris Group | 26.43B |